Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Acute Myeloid Leukemia
100%
Chemotherapy
100%
Tyrosine Kinase
100%
Fetal Liver
100%
Kinase Inhibitor
100%
CXCR4 Inhibitor
100%
Overcoming Resistance
100%
Leukemia Microenvironment
100%
Leukemic Cells
80%
Stromal Cell-derived factor-1 (SDF-1)
80%
Apoptosis Induction
60%
Chemotherapy-induced
60%
Leukemia
40%
Stromal Cells
40%
Acute Myeloid Leukemia Cells
40%
Sorafenib
40%
AMD3465
40%
Bone Marrow Microenvironment
40%
CXCR4 Signaling
40%
Induced Activation
20%
Cell-to-cell
20%
Granulocyte Colony-stimulating Factor (G-CSF)
20%
Physiologic
20%
Gene mutation
20%
Antileukemic Activity
20%
Protective Effect
20%
Prolonged Survival
20%
Human Mesenchymal Stem Cells (hMSCs)
20%
Progenitor Cells
20%
Microenvironment
20%
Pro-survival
20%
C-X-C Chemokine Receptor Type 4 (CXCR4)
20%
Chemotaxis
20%
Anti-leukemia
20%
Signal Transduction Inhibitors
20%
Microbe-microbe Interactions
20%
Chemotherapy Effect
20%
Apoptogenic
20%
Biochemistry, Genetics and Molecular Biology
Kinase
100%
Phosphotransferase
100%
Myeloid
100%
CXCR4
100%
Receptor Tyrosine Kinase
62%
Tyrosine Kinase
62%
Stromal Cell-Derived Factor 1
50%
Programmed Cell Death
37%
Stromal Cell
37%
Signal Transduction
25%
Sorafenib
25%
Gene Mutation
12%
Granulocyte Colony-Stimulating Factor
12%
Progenitor Cell
12%
Coculture
12%
In Vivo Study
12%
Chemotaxis
12%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Myeloid Leukemia
100%
Leukemia
100%
Phosphotransferase Inhibitor
100%
Protein Kinase Fer
100%
Chemotherapy Regimen
100%
Stromal Cell Derived Factor 1
80%
Sorafenib
40%
N [1,4,8,11 Tetraazacyclotetradecanyl 1,4 Phenylenebis(methylene)] 2 (Aminomethyl)pyridine
40%
Granulocyte Colony Stimulating Factor
20%